Join
Live feed
·
INSIDERFilingvia Quantisnow
Impact BioMedical Inc. logo

Chief Executive Officer Heuszel Frank D bought $1,129 worth of shares (500 units at $2.26), increasing direct ownership by 0.52% to 97,344 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
IBO· Impact BioMedical Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track IBO (Impact BioMedical Inc.) and more on Quantisnow.